Related Experiment Video

Updated: Feb 6, 2026

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
06:28

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients

Published on: June 24, 2019

9.9K

Is Procalcitonin Useful in Pediatric Critical Care Patients?

Sara Bobillo-Perez1, Javier Rodríguez-Fanjul2, Iolanda Jordan Garcia3

  • 1Pediatric Intensive Care Unit Service, Research Group of the Pediatric Critical Patient, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.

Biomarker Insights
|August 11, 2018
PubMed

Insights

Procalcitonin is a valuable biomarker for diagnosing pediatric infections and monitoring treatment response, particularly in intensive care settings. This review highlights its clinical utility in managing critically ill children.

Area of Science:

  • Pediatric critical care medicine
  • Biomarker research
  • Infectious disease diagnostics

Background:

  • Procalcitonin (PCT) is a precursor to calcitonin, increasingly recognized for its role in inflammation and infection.
  • Accurate diagnostic tools are crucial for timely intervention in pediatric infectious diseases.
  • Pediatric intensive care units (PICUs) require reliable markers for patient management.

Purpose of the Study:

  • To review the current evidence on procalcitonin's utility in pediatric patients.
  • To emphasize its application in intensive care settings.
  • To assess procalcitonin as a biomarker for infection diagnosis and treatment monitoring.

Main Methods:

  • Systematic literature review of recent articles.
  • Analysis of studies focusing on procalcitonin in pediatric populations.
  • Evaluation of procalcitonin's performance in diagnosing infections and guiding therapy.

Main Results:

  • Procalcitonin demonstrates significant potential as a biomarker in pediatric infections.
  • Its levels correlate with infection severity and response to antimicrobial therapy.
  • Evidence supports its use in differentiating bacterial from viral infections.

Conclusions:

  • Procalcitonin is a promising biomarker for pediatric infectious diseases, especially in critical care.
  • It aids in early diagnosis and optimizing antibiotic treatment strategies.
  • Further research can solidify its role in routine pediatric clinical practice.

Keywords:
PCTPICUbiomarkerinfectionsstewarship

More Related Videos

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.9K
Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.3K

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
Critical Region, Critical Values and Significance Level01:16

Critical Region, Critical Values and Significance Level

The critical region, critical value, and significance level are interdependent concepts crucial in hypothesis testing.
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in  probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
13.4K